Prime Medicine, Inc. financial data

Symbol
PRME on Nasdaq
Location
Cambridge, MA
Fiscal year end
31 December
Latest financial report
03 Mar 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 495% % -29%
Debt-to-equity 196% % 267%
Return On Equity -179% % -78%
Return On Assets -60% % 7.6%
Operating Margin -4498% % 34%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 180,552,179 shares 38%
Common Stock, Shares, Outstanding 180,514,014 shares 38%
Entity Public Float $238,759,057 USD -20%
Common Stock, Value, Issued $2,000 USD 0%
Weighted Average Number of Shares Outstanding, Basic 148,758,527 shares 25%
Weighted Average Number of Shares Outstanding, Diluted 148,758,527 shares 25%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $4,632,000 USD 55%
Research and Development Expense $160,636,000 USD 3.4%
General and Administrative Expense $52,346,000 USD 4.4%
Operating Income (Loss) $208,350,000 USD -2.9%
Nonoperating Income (Expense) $7,208,000 USD 9.5%
Income Tax Expense (Benefit) $0 USD
Net Income (Loss) Attributable to Parent $201,142,000 USD -2.7%
Earnings Per Share, Basic -1.35 USD/shares 18%
Earnings Per Share, Diluted -1.35 USD/shares 18%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $63,032,000 USD -65%
Cash, Cash Equivalents, and Short-term Investments $177,700,000 USD -6.7%
Other Assets, Current $674,000 USD -95%
Assets, Current $181,293,000 USD -14%
Property, Plant and Equipment, Net $20,572,000 USD -16%
Operating Lease, Right-of-Use Asset $126,177,000 USD 168%
Other Assets, Noncurrent $1,000,000 USD
Assets $342,733,000 USD 15%
Accounts Payable, Current $8,887,000 USD -22%
Employee-related Liabilities, Current $7,337,000 USD -18%
Accrued Liabilities, Current $12,600,000 USD -21%
Contract with Customer, Liability, Current $7,824,000 USD 10%
Liabilities, Current $37,448,000 USD -1.4%
Contract with Customer, Liability, Noncurrent $58,127,000 USD -8.1%
Deferred Income Tax Liabilities, Net $134,000 USD 74%
Operating Lease, Liability, Noncurrent $108,290,000 USD 191%
Liabilities $221,865,000 USD 54%
Accumulated Other Comprehensive Income (Loss), Net of Tax $82,000 USD 8100%
Retained Earnings (Accumulated Deficit) $888,354,000 USD -29%
Stockholders' Equity Attributable to Parent $120,868,000 USD -21%
Liabilities and Equity $342,733,000 USD 15%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $48,857,000 USD 28%
Net Cash Provided by (Used in) Financing Activities $6,000,000 USD -96%
Net Cash Provided by (Used in) Investing Activities $47,742,000 USD -29%
Common Stock, Shares Authorized 775,000,000 shares 0%
Common Stock, Shares, Issued 180,514,014 shares 38%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $90,599,000 USD -272%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $76,723,000 USD -61%
Deferred Tax Assets, Valuation Allowance $239,413,000 USD 33%
Deferred Tax Assets, Gross $273,904,000 USD 42%
Operating Lease, Liability $116,427,000 USD 185%
Payments to Acquire Property, Plant, and Equipment $2,422,000 USD 4.2%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $201,061,000 USD -2.7%
Lessee, Operating Lease, Liability, to be Paid $184,431,000 USD -11%
Property, Plant and Equipment, Gross $41,006,000 USD 7.9%
Operating Lease, Liability, Current $8,137,000 USD 125%
Lessee, Operating Lease, Liability, to be Paid, Year Two $22,355,000 USD -4.4%
Lessee, Operating Lease, Liability, to be Paid, Year One $21,703,000 USD 9.8%
Operating Lease, Weighted Average Discount Rate, Percent 0.1224 pure -4.6%
Deferred Income Tax Expense (Benefit) $0 USD -100%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $68,004,000 USD 134%
Lessee, Operating Lease, Liability, to be Paid, Year Three $22,294,000 USD -2.7%
Deferred Tax Assets, Operating Loss Carryforwards $116,777,000 USD 90%
Lessee, Operating Lease, Liability, to be Paid, Year Four $21,478,000 USD -3.7%
Additional Paid in Capital $1,009,138,000 USD 20%
Depreciation, Depletion and Amortization $7,321,000 USD 19%
Share-based Payment Arrangement, Expense $29,268,000 USD 12%